Quick Answer
IDEXX LABORATORIES INC /DE reported Diluted EPS of $13.08 per share for fiscal year 2025.
IDEXX LABORATORIES INC /DE Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $13.08 | +22.6% |
| 2024 | $10.67 | +6.1% |
| 2023 | $10.06 | +25.3% |
| 2022 | $8.03 | -6.6% |
| 2021 | $8.60 | +28.2% |
| 2020 | $6.71 | +37.2% |
| 2019 | $4.89 | +14.8% |
| 2018 | $4.26 | +44.9% |
| 2017 | $2.94 | +20.5% |
| 2016 | $2.44 | +19.0% |
| 2015 | $2.05 | +14.5% |
| 2014 | $1.79 | +2.9% |
| 2013 | $1.74 | -45.1% |
| 2012 | $3.17 | +14.0% |
| 2011 | $2.78 | +17.3% |
| 2010 | $2.37 | +17.9% |
| 2009 | $2.01 | +7.5% |
| 2008 | $1.87 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.40 | +21.4% | -6.3% |
| June 30, 2025 | $3.63 | +48.8% | +22.6% |
| March 31, 2025 | $2.96 | +5.3% | +5.7% |
| September 30, 2024 | $2.80 | +10.7% | +14.8% |
| June 30, 2024 | $2.44 | -8.6% | -13.2% |
| March 31, 2024 | $2.81 | +10.2% | +11.1% |
| September 30, 2023 | $2.53 | +17.7% | -5.2% |
| June 30, 2023 | $2.67 | +71.2% | +4.7% |
- IDEXX LABORATORIES INC /DE showed an increase of +22.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, IDEXX LABORATORIES INC /DE’s diluted eps has grown by 599.5% (from $1.87 per share to $13.08 per share).
- The most recent figure is from IDEXX LABORATORIES INC /DE’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: